The Manufacturers Life Insurance Company Trims Stake in Cigna Group $CI

The Manufacturers Life Insurance Company reduced its stake in Cigna Group (NYSE:CI) by 3.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 875,333 shares of the health services provider’s stock after selling 28,542 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Cigna Group were worth $241,312,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group in the fourth quarter worth about $25,000. Osbon Capital Management LLC purchased a new position in shares of Cigna Group during the 2nd quarter valued at about $26,000. Cedar Mountain Advisors LLC lifted its position in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares in the last quarter. Johnson Financial Group Inc. bought a new position in shares of Cigna Group during the 2nd quarter valued at approximately $29,000. Finally, Fiduciary Financial Advisors purchased a new stake in Cigna Group in the 2nd quarter worth approximately $29,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

Shares of NYSE:CI opened at $280.32 on Friday. The firm has a fifty day simple moving average of $283.45 and a two-hundred day simple moving average of $280.78. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $74.07 billion, a P/E ratio of 11.60, a PEG ratio of 0.96 and a beta of 0.31.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter last year, the firm earned $7.20 EPS. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts expect that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is presently 25.82%.

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 617 shares of Cigna Group stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

CI has been the topic of a number of recent analyst reports. Guggenheim raised their target price on shares of Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Piper Sandler reduced their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 29th. Robert W. Baird set a $362.00 price objective on shares of Cigna Group in a research report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their target price for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $337.10.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.